← Back to Search

Lithotripsy Technology

MOSES Laser Technology for Kidney Stones

N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Kidney or ureteral stone requiring laser lithotripsy fragmentation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial is testing if using a laser to fragment kidney stones is more efficient and safe when a specific type of modulation is used.

Who is the study for?
This trial is for adults over 18 with kidney or ureteral stones needing laser fragmentation. It's not suitable for those under 18, patients with infectious struvite stones, or unusual urinary tract anatomy that could complicate the procedure.Check my eligibility
What is being tested?
The study tests MOSES laser technology during ureteroscopy to see if it can make breaking up kidney stones safer and more efficient, potentially reducing the time spent using the laser and overall operating room time.See study design
What are the potential side effects?
While specific side effects are not listed, typical risks of laser lithotripsy may include bleeding, infection, stone fragments blocking urine flow, and discomfort from the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I need a laser treatment for my kidney or ureter stone.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The primary endpoint of interest will be reduction in total OR time
The primary endpoint of interest will be reduction in total laser time
Secondary outcome measures
Complication rates using Clavien-Dindo score

Trial Design

2Treatment groups
Active Control
Group I: MOSES laser lithotripsyActive Control1 Intervention
MOSES technology used for stone fragmentation in ureteroscopy
Group II: Standard laser lithotripsyActive Control1 Intervention
standard of care for stone fragmentation in ureteroscopy

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
977 Previous Clinical Trials
983,197 Total Patients Enrolled
4 Trials studying Kidney Stones
173 Patients Enrolled for Kidney Stones

Media Library

MOSES (Lithotripsy Technology) Clinical Trial Eligibility Overview. Trial Name: NCT03995758 — N/A
Kidney Stones Research Study Groups: MOSES laser lithotripsy, Standard laser lithotripsy
Kidney Stones Clinical Trial 2023: MOSES Highlights & Side Effects. Trial Name: NCT03995758 — N/A
MOSES (Lithotripsy Technology) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03995758 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been recruited for this trial thus far?

"Affirmative, the information hosted on clinicaltrials.gov shows that this research project is currently searching for volunteers. The initial posting date was June 6th 2019 and it has been recently updated in July 2021. 32 participants are required from a single trial site."

Answered by AI

Are there still openings for individuals to participate in this clinical trial?

"Right. According to data hosted on clinicaltrials.gov, this experiment is actively enrolling patients and has been since June 6th 2019. 32 participants are needed from a single site for its completion, with the trial's information most recently modified on July 29 2021."

Answered by AI
~2 spots leftby May 2024